For Immediate Release 17 September 2019
MILLENNIUM & COPTHORNE HOTELS PLC ("THE COMPANY")
NOTIFICATION OF TRANSACTION OF PERSON DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMR'S") AND PERSON CLOSELY ASSOCIATED WITH THEM ("PCA'S")
Provided in accordance with Article 19.3 of the EU Market Abuse Regulation No. 596/2014
LEI Number: 2138003EQ1O4LZ1JNH19
1
|
Details of person discharging managerial responsibilities / person closely associated |
|||||
a) |
Details of PDMR/PCA |
Clive Harrington |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Chief Commercial Officer |
||||
b) |
Initial notification/
|
Initial notification |
||||
|
Amendment |
|
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Full name of the entity |
Millennium & Copthorne Hotels plc |
||||
b) |
Legal Entity |
2138003EQ104LZ1JNH19 |
||||
|
Identifier code |
|
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each |
|||||
|
type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument
|
Ordinary Shares of 30p each
|
||||
b) |
Identification code |
GB0005622542 |
||||
c) |
Nature of the transaction |
Dematerialising of certificated holding involving the transfer of 8,852 ordinary shares in the Company to the PDMR's account with a nominee, Hargreaves Lansdown Nominees Limited, with no change to the beneficial interest of those ordinary shares. |
||||
d) |
Currency |
Sterling |
||||
e) |
Price(s) and volume(s) |
|
||||
f) |
Aggregated information
- Aggregated volume
- Price
- Total
- - Price
|
N/A Single Transaction |
||||
g) |
Date of the transaction |
12 September 2019 |
||||
h) |
Place of the transaction |
Outside of a trading venue
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.